the aid library

LIST OPTIONS

Filter

10747

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (4292)

View PDF (3595)

Standard Treatment Guidelines. Nigeria

Federal Ministry of Health Nigeria , World Health Organisation (WHO) (2008) C_WHO

Download (2241)

View PDF (1582)

Clinic Supervisor Manual

Management Sciences for Health; USAID (2006) C1

This Clinic Supervisor’s Manual is helpful for focusing managers on the key elements of integrated primary health care as they simultaneously integrate new interventions for HIV/AIDS, tuberculosis, and malaria. This tool contains 12 sections. Section 1 explains how to use the manual. Section 2 hel... more

Download (875)

View PDF (1587)

SENSIBILIZAÇÃO SOBRE O ÉBOLA

International SOS (2014)

Download (929)

View PDF (2109)

Ebola Awareness Talk

International SOS (2014)

External Link

Strategic Plan of Action and Budget 2016 – 2025 for Elimination of Onchocerciasis in Africa

World Health Organization WHO African Prgramme for Onchocerciasis Control (2012) C_WHO

The Strategic Plan of Action and Budget 2016-2025 for the elimination of onchocerciasisin countries was prepared based on the above dlrective for the consideration of IAF 18.The vision of the plan of action is to eliminate onchocerciasis in 80 percent of Africancountries. Implementation of the plan ... more

Download (318)

View PDF (457)

World Drug Report 2019 Booklet 3 Drug market trends of Cannabis and Opioids

United Nations Office on Drug and Crime UNODC (2022) C2

This third booklet of the World Drug Report 2022 has a dual focus: opioids and cannabis. The first chapter of the booklet provides an overview of opioids as a group of substances and their patterns of non-medical use at the global level. It also reviews the latest trends in the global supply of opi... more

Download (1419)

View PDF (1995)

World Health Organization model list of essential medicines for children: 8th list
recommended

World Health Organization WHO (2021) C_WHO

WHO’s Essential Medicines List and List of Essential Diagnostics are core guidance documents that help countries prioritize critical health products that should be widely available and affordable throughout health systems. The updated Essential Medicines List adds 23 medicines for children.

Download (301)

View PDF (417)

World Drug Report 2019 Booklet 1 Executive summary / Policy implications

United Nations Office on Drug and Crime UNODOC (2022) C1

The World Drug Report 2022 is aimed not only at fostering greater international cooperation to counter the impact of the world drug problem on health, governance and security, but also, with its special insights, at assisting Member States in anticipating and address-ing threats from drug markets an... more

Download (132)

View PDF (258)

Ghana - Country Cooperation Strategy 2024 - 2028

World Health Organization WHO (2025) C_WHO

The development of the Country Cooperation Strategy (CCS) was based on a consultative and participatory process with strong commitment and support from the Ministry of Health of Ghana. The CCS draws on lessons from the implementation of the first, and second generation CCSs, the country focus strate... more

Download (520)

View PDF (1079)

Integrating palliative care and symptom relief into responses to humanitarian emergencies and crises: a WHO guide

World Health Organization WHO (2018) C_WHO

Humanitarian emergencies and crises (Humanitarian emergencies and crises) are large-scale events that may result in the breakdown of health care systems and society, forced displacement, death, and physical, psychological, social and spiritual suffering on a massive scale. Current responses to Human... more

Download (1063)

View PDF (3047)

Ebola Awareness Toolbox Talk Arabic

International SOS (2014)

Download (209)

View PDF (259)

How Alcohol harm young people and what you can do about it

World Health Organization (Western Pacific Region) (2015) C_WHO

Download (279)

View PDF (254)

Global Vaccine Market Report 2022

World Health Organization WHO (2022) C_WHO

The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized ... more

Download (403)

View PDF (709)

Situation Analysis of Children in South Africa

United Nations Children's Fund (UNICEF) (2009)

External Link

Gleiche Rechte für Frauen und Männer

TERRE DES FEMMES (2016) C1

Der Flyer Gleiche Rechte für Frauen und Männer informiert darüber, dass in Deutschland für Frauen und Männer die gleichen Rechte gelten. Der Text, in dem verdeutlicht wird, dass geschlechtsspezifische Gewaltformen in Deutschland verboten sind, ist jetzt auch in Bulgarisch, Rumänisch, Russisch,... more

Download (1056)

View PDF (2534)

Information sur Ebola. Outil de communication

International SOS (2014)

Download (89)

View PDF (76)

Plan of Action for Malaria Elimination 2021-2025

Pan American Health Organization (PAHO) (2022) C_WHO

The Plan of Action for Malaria Elimination 2021-2025 has been developed in consultation with countries and regional partners as a framework of reference to guide the efforts of countries and the contributions of donors and partners towards elimination of the disease in the Americas. The Plan subscri... more

Download (657)

View PDF (1993)

Crisis and Emergency Risk Communication Quick Guide

Centers for Disease Control and Prevention (2008) C_CDC

Download (461)

View PDF (791)

How to recognize and initially respond to an accidental radiation injury

World Health Organization, International Atomic Energy Agency (2000) C_WHO

This leaflet is intended to inform physicians — mainly GPs — and medical students on how to recognize a possible radiation injury. It is important to note that radiation injury has no special signs and symptoms. However, the combination of some of them may be typical of radiation injury. Arabic... more

World Health Organization model list of essential medicines for children: 8th list recommended

World Health Organization model list of essential medicines for children: 8th list
recommended